Therefore, we propose that efficient PR-B-mediated effects require PTEN action and that the PR-B/PTEN functional interplay has the ability to modulate cell survival signalling, extending the beneficial role of this nuclear receptor on breast cancer cells. The gene discussed is PTEN; the disease is breast carcinoma.